Buspirone Hcl Tablet
Product Images NDC 72888-062

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Buspirone Hcl (NDC 72888-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buspirone HCl Tablets,usp 10 mg (NDC 72888-064-01)

This is information about Buspirone Hydrochloride tablets. Each tablet contains 10 mg of the active ingredient and should be stored in a tight container at room temperature. There is a patient instruction sheet included with the medication, which should be dispensed by the pharmacist to each patient. The usual dosage information can be found in the package insert. The manufacturer is Rubicon Research Pvt. Ltd. and the distributor is Advagen Pharma Limited based out of Plainsboro NJ.*

FDA Label Image

Buspirone HCl Tablets,usp 10 mg (NDC 72888-064-05)

FDA Label Image

Buspirone HCl Tablets,usp 15 mg (NDC 72888-065-01)

This is a medication called Buspirone, which is packaged in a container with a National Drug Code (NDC) of 72888-065-01. Each tablet contains 15mg of Buspirone Hydrochloride, and the usual dosage is specified in the package insert. The tablets should be stored in a light-resistant container at temperatures between 20°C to 25°C (68°F to 77°F). The medication is manufactured by Rubicon Research Private Limited in India and distributed by Advagen Pharma Limited. A patient information sheet is available on the company's website.*

FDA Label Image

Buspirone HCl Tablets,usp 15 mg (NDC 72888-065-05)

This is a description of Buspirone Hydrochloride tablets containing 15mg of the active ingredient. The tablets should be stored in a light-resistant container at room temperature (20°C to 25°C or 68°F to 77°F) and kept out of reach of children. The usual dosage instructions can be found in the package insert, along with a patient information sheet available at www.advagenpharma.com/medguide/buspironetablets. The tablets are distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The accompanying patient instruction sheet should be dispensed by the pharmacist.*

FDA Label Image

Buspirone HCl Tablets,usp 15 mg (NDC 72888-065-60)

This is a medication description for Buspirone Hydrochloride tablets containing 15mg USP. The recommended dosage is available in the package insert. It is advised to keep the medication in a tight and light-resistant container away from children at temperatures between 20-25°C. The medication is distributed by Advagen Pharma with accompanying patient instruction sheets. It is also manufactured by Rubicon Research in India, and the package contains 60 tablets. No additional information is available.*

FDA Label Image

Buspirone HCl Tablets,usp 30 mg (NDC 72888-066-05)

Each tablet contains 30mg Buspirone Hydrochloride as defined in the USP. Tablets should be dispensed in a tight, light-resistant container and stored at 20-25°C. Usual dosage should be consulted in the package insert. Patient Information Sheet available at www.advagenpharma.com/medguide/buspironetablets. Distributed by Advagen Pharma Limited based in Plainsboro, NJ, USA. Manufacturing license number is KD-682. Manufactured by Rubicon Research Private Limited based in Ambernath, India. A patient instruction sheet should be dispensed to each patient by a pharmacist.*

FDA Label Image

Buspirone HCl Tablets,usp 30 mg (NDC 72888-066-60)

This is a medication package insert for Buspirone Hydrochloride USP tablets with a usual dosage recommendation of 30mg. The tablets should be stored in a tightly sealed, light-resistant container at room temperature and out of reach of children. The patient information sheet can be accessed at www.advagenpharma.com/medguide/buspironetablets. The product is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. It is advised to dispense the patient instruction sheet with each prescription.*

FDA Label Image

Buspirone HCl Tablets,usp 5 mg (NDC 72888-062-01)

Each tablet contains 5mg of Buspirone Hydrochloride, a light-resistant drug used for anxiety. The tablets are packed in a tight light-resistant container and have a usual dosage that can be found in the package insert. They should be kept out of reach of children and stored at a temperature ranging from 20°C to 25°C. The manufacturer is Advagen Pharma Limited, and the tablet is distributed by Bainsboro, NJ. This information is for pharmacist dispensation and should be accompanied by a Patient Instruction Sheet.*

FDA Label Image

Buspirone HCl Tablets,usp 5 mg (NDC 72888-062-05)

Each tablet contains 5mg of Buspirone Hydrochloride as defined in the USP. The tablets are to be dispensed in a tight, light-resistant container. The manufacturer, Rubicon Research Private Limited, is based in Ambernath, India. The tablets are distributed in the US by Lannett Company, Inc. The label advises to store the tablets at 20°C to 25°C and to keep them out of reach of children. The package insert and patient information sheet are also available. The NDC for the tablets is 72888-062-05.*

FDA Label Image

Buspirone HCl Tablets,usp 7.5 mg (NDC 72888-063-01)

Buspirone is a medication available in 7.5mg tablets, typically used for anxiety. The recommended dosage and storage instructions can be found in the package insert, with storage recommended between 20°C-25°C. Each tablet should be dispensed in a light-resistant container and kept away from children. For further information and patient instructions, visit www.advagenpharma.com/medguide/buspironetablets. This medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The NDC number for this medication is 72888-063-01.*

FDA Label Image

Buspirone HCl Tablets,usp 7.5 mg (NDC 72888-063-05)

This is a medication label for Buspirone Hydrochloride tablets, each containing 7.5 mg strength. The usual dosage details are mentioned on the package insert. These tablets should be stored at a temperature of 20°C to 25°C, protected from light, and dispensed in a tightly closed container. The patient information sheet is available on the manufacturer's website, and one must contact the pharmacist for the Patient Instruction Sheet. Distributed by Advagen Pharma Limited, these tablets are manufactured in India by Rubicon Research Private Limited. The label contains the NDC number, manufacturing license number, and a revision date code.*

FDA Label Image

1 (Buspirone HCl Tab Usp Structure 1)

FDA Label Image

2 (Buspirone HCl Tab Usp Structure 2)

FDA Label Image

3 (Buspirone HCl Tab Usp Structure 3)

FDA Label Image

4 (Buspirone HCl Tab Usp Structure 4)

FDA Label Image

5 (Buspirone HCl Tab Usp Structure 5)

FDA Label Image

Structure (Buspirone HCl Tab Usp Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.